Researchers at the University of Washington’s Institute for Protein Design have engineered larger, virus-like protein cages to one day deliver larger genetic payloads. Read More
The Washington Research Foundation is investing $7 million in Nobel laureate David Baker’s UW lab to turn AI-designed proteins into real-world tools. Read More
A vaccine with University of Washington roots that fights a suite of coronaviruses including COVID-19 and related, deadly diseases is starting human clinical testing. Read More
A Seattle biotech startup born from a Nobel laureate’s lab has landed $12.7 million and partnerships with pharmaceutical giants Pfizer and Kite Pharma by using AI to design proteins that mount a multi-pronged attack on diseases. Read More
Researchers from Nobel Laureate David Baker’s lab at the University of Washington have successfully used AI to design antibodies from scratch. Read More
Mary Brunkow of the Seattle-based Institute for Systems Biology, Fred Ramsdell of Sonoma Biotherapeutics, and David Baker of the UW’s Institute for Protein Design were honored for their research. Read More
Lila Biologics hopes to hand off a candidate protein within three to six months so the pharmaceutical giant can take the drug through clinical trials. Read More
The wiggly targets known to scientists as “intrinsically disordered proteins” have for decades eluded capture by custom-made drugs and antibodies.… Read More
